Gemini named Donald O’Neil as chief commercial officer. Don has over 20 years of relevant life sciences experience. His previous roles include responsibilities for Invitrogen’s global reagents business, now owned by Thermo Fisher, and MilliporeSigma’s Cell Biology and Detection Solutions business segments. He was most recently senior vice president of sales and Strategic Partnerships at ORFLO Technologies, a life science instruments company. He will lead Gemini’s commercial efforts across a 14-p...